• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Del Global reconciles with shareholders

Article

Trying to settle a lawsuit initiated in November after accounting irregularities were uncovered, Del Global has reached a tentative deal with shareholders. Under the agreement, Del will contribute $2 million in a subordinated note due in five years with

Trying to settle a lawsuit initiated in November after accounting irregularities were uncovered, Del Global has reached a tentative deal with shareholders. Under the agreement, Del will contribute $2 million in a subordinated note due in five years with interest at 6% per annum, 2.5 million shares of Del stock, and warrants to purchase one million shares exercisable at $2.00 per share, expiring in six years. The plaintiffs will also receive a $2 million cash payment to which Del will not contribute. The courts must yet approve the deal. In a separate action, Samuel E. Park has been appointed president and CEO of Del. Park has acted in this capacity since February.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.